Aryavan Enterprise Ltd Q4 Results
- BSE: 539455
- NSE: -
- ISIN: INE360S01012
- Sector: Biotechnology & Drugs
BSE
56.80
2.93 (5.44%)
2.93 (5.44%)Volume13.84 K
Updated: Wed 11 Feb, 2026 | 15:23:12
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 25
Note: Comparison is on QoQ basis
Quarterly - Aryavan Enterprise Ltd Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 24 | QoQ Comp |
|---|---|---|---|
| Total Operating Expense | 13.33 | 8.66 | 54.04% |
| Depreciation/ Amortization | 0.07 | 0.01 | 614.58% |
| Operating Income | 0.82 | 0.29 | 184.88% |
| Net Income | 0.59 | 0.25 | 134.08% |
| Other Operating Expenses Total | 0.81 | 0.03 | 2421.56% |
| Net Income Before Taxes | 0.97 | 0.36 | 165.71% |
| Total Revenue | 14.15 | 8.94 | 58.25% |
| Selling/ General/ Admin Expenses Total | 0.39 | 0.09 | 329.44% |
| Diluted Normalized EPS | 1.28 | 0.54 | 136.62% |